Related Experiment Video

Updated: Jun 2, 2026

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
03:25

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease

Published on: December 27, 2024

Racecadotril for childhood gastroenteritis: an individual patient data meta-analysis

Philippe Lehert1, Gérard Chéron, Guillermo Alvarez Calatayud

  • 1Statistics Department, Faculty of Economics, FUCAM, Louvain Academy, Belgium. philippe.lehert@gmail.com

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
|April 26, 2011
PubMed

Insights

Racecadotril, an antidiarrhoeal drug, significantly reduces diarrhea duration and stool output when used with oral rehydration solution. This treatment is effective for childhood acute gastroenteritis, regardless of initial conditions.

Area of Science:

  • Pharmacology
  • Gastroenterology
  • Clinical Trials

Background:

  • Racecadotril is an antidiarrhoeal medication.
  • It functions via an intestinal antisecretory mechanism.
  • Acute gastroenteritis in children is a common condition.

Purpose of the Study:

  • To evaluate the efficacy of racecadotril as an adjunct therapy.
  • Comparison against oral rehydration solution alone or with placebo.
  • Focus on childhood acute gastroenteritis treatment.

Main Methods:

  • Individual patient data meta-analysis.
  • Multilevel mixed-effects models were employed.
  • Baseline covariates were adjusted for treatment effect significance.

Main Results:

  • Nine randomized clinical trials (1384 patients) were analyzed.
  • Racecadotril significantly improved recovery rates (HR=2.04, p<0.001).
  • Reduced stool output in inpatient (0.59 ratio) and outpatient (0.63 ratio) settings.

Conclusions:

  • Baseline dehydration and Rotavirus infection are key factors in treatment comparison.
  • Racecadotril offers clinically relevant benefits in reducing diarrhea.
  • Efficacy is consistent across various baseline conditions and study settings.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...